|
gptkbp:instance_of
|
gptkb:Oncology
|
|
gptkbp:affects
|
blood vessels
|
|
gptkbp:age_group
|
adults
|
|
gptkbp:chemotherapy_agent
|
gptkb:gemcitabine
gptkb:doxorubicin
gptkb:ifosfamide
|
|
gptkbp:clinical_trial
|
gptkb:immunotherapy
biomarkers
new therapies
|
|
gptkbp:condition
|
gptkb:Kaposi's_sarcoma
hemangioma
|
|
gptkbp:diagnosis
|
gptkb:MRI
CT scan
variable
imaging studies
ultrasound
biopsy
|
|
gptkbp:emissions_standard
|
external beam radiation
|
|
gptkbp:epidemiology
|
risk factors
incidence rate
prevalence rate
|
|
gptkbp:events
|
symptom management
clinical evaluations
regular imaging
|
|
gptkbp:first_described_by
|
gptkb:1942
|
|
gptkbp:gender_predominance
|
male
|
|
gptkbp:genetic_studies
|
chromosomal abnormalities
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
hemangiopericytoma
|
|
gptkbp:is_located_in
|
gptkb:Headcrab
pelvis
legs
|
|
gptkbp:occurs_in
|
rare
|
|
gptkbp:origin
|
pericytes
|
|
gptkbp:patient_population
|
age
gender
ethnicity
|
|
gptkbp:provides_guidance_on
|
ASCO guidelines
ESMO guidelines
NCCN guidelines
|
|
gptkbp:research_focus
|
molecular biology
genetic mutations
treatment efficacy
|
|
gptkbp:scientific_classification
|
WHO grade
histological type
|
|
gptkbp:specialties
|
amputation
wide excision
|
|
gptkbp:symptoms
|
fatigue
weight loss
fever
pain
swelling
|
|
gptkbp:treatment
|
gptkb:surgery
radiation therapy
chemotherapy
recurrence
metastasis
|
|
gptkbp:type
|
gptkb:Kaposi's_sarcoma
|
|
gptkbp:bfsParent
|
gptkb:letrozole
|
|
gptkbp:bfsLayer
|
6
|